| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.087 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |